Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S G Gourlay

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
European Journal of Clinical Pharmacology|January 1, 1997
Determinants of plasma concentrations of nicotine and cotinine during cigarette smoking and transdermal nicotine treatmentS G Gourlay, N L Benowitz, A Forbes, et al.
BMJ (Clinical Research Ed.)|August 5, 1995
Double blind trial of repeated treatment with transdermal nicotine for relapsed smokersS G Gourlay, A Forbes, T Marriner, et al.
Journal of the American College of Cardiology|November 13, 2001
Cardiovascular effects of carbon monoxide and cigarette smokingS Zevin, S Saunders, S G Gourlay, et al.
BMJ (Clinical Research Ed.)|October 1, 1994
Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessationS G Gourlay, A Forbes, T Marriner, et al.
Journal of Human Hypertension|October 1, 1993
Discordance of mercury sphygmomanometer and ambulatory blood pressure measurements for the detection of untreated hypertension in a population studyS G Gourlay, J J McNeil, T Marriner, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|May 1, 1995
A cohort study comparing the detection of HPV DNA from women who stop and continue to smokeC K Fairley, S N Tabrizi, S G Gourlay, et al.
Circulation|December 6, 2001
Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) studyK W Baran, M Nguyen, G R McKendall, et al.
The British Journal of Dermatology|May 4, 2021
Proof of concept for the clinical effects of oral rilzabrutinib, the first Bruton tyrosine kinase inhibitor for pemphigus vulgaris: the phase II BELIEVE studyD F Murrell, A Patsatsi, P Stavropoulos, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
European Journal of Clinical Pharmacology|January 1, 1997
Determinants of plasma concentrations of nicotine and cotinine during cigarette smoking and transdermal nicotine treatmentS G Gourlay, N L Benowitz, A Forbes, et al.
BMJ (Clinical Research Ed.)|August 5, 1995
Double blind trial of repeated treatment with transdermal nicotine for relapsed smokersS G Gourlay, A Forbes, T Marriner, et al.
Journal of the American College of Cardiology|November 13, 2001
Cardiovascular effects of carbon monoxide and cigarette smokingS Zevin, S Saunders, S G Gourlay, et al.
BMJ (Clinical Research Ed.)|October 1, 1994
Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessationS G Gourlay, A Forbes, T Marriner, et al.
Journal of Human Hypertension|October 1, 1993
Discordance of mercury sphygmomanometer and ambulatory blood pressure measurements for the detection of untreated hypertension in a population studyS G Gourlay, J J McNeil, T Marriner, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|May 1, 1995
A cohort study comparing the detection of HPV DNA from women who stop and continue to smokeC K Fairley, S N Tabrizi, S G Gourlay, et al.
Circulation|December 6, 2001
Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) studyK W Baran, M Nguyen, G R McKendall, et al.
The British Journal of Dermatology|May 4, 2021
Proof of concept for the clinical effects of oral rilzabrutinib, the first Bruton tyrosine kinase inhibitor for pemphigus vulgaris: the phase II BELIEVE studyD F Murrell, A Patsatsi, P Stavropoulos, et al.
Pageof 2